Clinical Trial Update: Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

A Phase 4 trial in de novo kidney transplant recipients that evaluated converting from tacrolimus to a sirolimus-based regimen has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Drugs mentioned

• Prograf (Tacrolimus)
• Rapamune (sirolimus)

Snippet

Sponsor: Helio Tedesco Silva Junior | Conditions: Kidney Transplant | Phase 4 | Status: COMPLETED